InvestorsHub Logo
Followers 7
Posts 976
Boards Moderated 0
Alias Born 11/13/2018

Re: TR6767 post# 63805

Thursday, 01/16/2020 5:00:53 PM

Thursday, January 16, 2020 5:00:53 PM

Post# of 83055
You get no argument from me that a Q4 miss will be a disaster and completely unacceptable. New management would be justifiable if that happens IMO.

But I disagree with your premise that it's q3 holding us back. The big hit that took the price down into the .80's was after the FDA letter. The immediate aftermath of the q3 miss drove the SP down to the 1.30's and it had rebounded to the 1.70's. The ultimate damage done here was the FDA notice, so again I don't think it makes sense that good news on legalization would have no affect when bad news does.

You may be right on the exchange and I think that's largely the culprit. little regulation and no institutional money makes for manipulation.

And btw I'm not saying that CW shouldn't be valued higher, but 8x is unfounded to me. Based on the last Q I think 2-3 times valuation is warranted. I don't want CW to come down though, I want them to go up to raise the value of the sector.